Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a vaccine therapy with QS-21 adjuvant in patients with progressive prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• QS-21 adjuvant (QS-21 adjuvant)
• Vaccine therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED